Abstract:BACKGROUND Beta-carotene protects the body against free radicals that may damage the kidney and lead to the development of acute kidney injury and chronic kidney disease (CKD). Previous studies in animal models have demonstrated a potential protective effect of 30 mg/kg beta-carotene supplementation on renal ischemia/reperfusion injury and subsequently improved kidney function. The extension of these findings to humans, however, remains unclear. METHODS Our study leverages previously collected data from the Physicians' Health Study I (PHS I), a large-scale, long-term, randomized trial of middle-aged and older U.S. male physicians testing 50 mg beta-carotene (BC) every other day for primary prevention of cardiovascular disease and cancer. We examined the impact of randomized BC supplementation on self-reported incident CKD identified by self-reports stating "yes" to kidney disease from annual follow-up questionnaires from randomization in 1982 through the end of the randomized BC intervention at the end of 1995, and on CKD defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m 2 at the end of 1995. Analyses compared incident CKD between BC supplementation and placebo using Cox proportional hazards regression models and logistic regression. We also examined whether smoking status (current vs former/never smoker) or other factors modified the effect of randomized BC supplementation on CKD. RESULTS A total of 10,966 participants were randomized to BC, and 10,952 participants were randomized to a placebo group. Baseline characteristics between randomized BC groups were similar. There was no significant benefit between BC supplementation and self-reported incident CKD after adjusting for age and randomized aspirin treatment (HR = 0.97, 95%CI [0.86, 1.08], p-value = 0.56). Stratified by smoking status, there was no significant benefit of BC supplementation and self-reported incident CKD either among former/never smokers (HR = 0.95, 95%CI [0.84, 1.07], p-value = 0.41) or current smokers (HR = 1.08, 95% CI [0.78, 1.50], p-value = 0.64). Smoking status did not modify the association between BC supplementation and incident CKD (p-interaction = 0.47). In subgroup analysis among those with available serum creatinine at the study end (5,480 with BC and 5,496 with placebo), there was no significant benefit between BC supplementation and CKD based on estimated glomerular filtration (eGFR) < 60 ml/min/1.73 m 2 (OR = 0.96, 95%CI [0.85, 1.08], p-value = 0.49). CONCLUSION Long-term randomized BC supplementation did not affect the risk of incident CKD in middle-aged and older male physicians.

Beta-carotene reduces oxidative stress, improves glutathione metabolism and modifies antioxidant defense systems in lead-exposed workers

The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead

Reduction of blood lead levels in lead-exposed mice by dietary supplements and natural antioxidants.

The effect of occupational chronic lead exposure on the complete blood count and the levels of selected hematopoietic cytokines

Comparison of toxic effects of lead and copper and protective power of glutathione on oxidative stress parameters

Ameliorative Role of β-Carotene on Some Adverse Biochemical Effects Induced by γ-Radiation in Rats

The Effect of Randomized Beta-carotene Supplementation on Chronic Kidney Disease in Men

Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning

Effects of Gamma-Tocopherol Supplementation on Thrombotic Risk Factors

Blood pressure and renal function responses in workers exposed to lead for up to six years

Exogenous glutathione attenuates lead-induced oxidative stress in wheat by improving antioxidant defense and physiological mechanisms

A STUDY ON OXIDATIVE STRESS IN LEAD-EXPOSED WORKERS

Concentration of Selected Elements and Antioxidative Potential in a Group of Males Working in the Metal Industry: Elements And Antioxidative Potential In Men

Role of Beta-Carotene in Lung Cancer Primary Chemoprevention: A Systematic Review with Meta-Analysis and Meta-Regression

Lead-induced oxidative damage in rats/mice: A meta-analysis

Role of wormwood (Artemisia absinthium) extract on oxidative stress in ameliorating lead induced haematotoxicity

[Effects on Human Peripheral Erythrocytes of Long-Term Occupational Contact with Chromate].

Relationship of serum carotenoid concentrations with allostatic load as a measure of chronic stress among middle-aged adults in the USA

Elevated, sustained, and yet reversible biotoxicity effects of lead on cessation of exposure: Melatonin is a potent therapeutic option

Protective Effects of Salidroside on Lead Acetate-induced Oxidative Stress and Hepatotoxicity in Sprague-Dawley Rats

Protective Effects of Dietary Supplements Containing Probiotics, Micronutrients, and Plant Extracts Against Lead Toxicity in Mice